Launch of Tome Biosciences, AI scientist, mRNA vaccines
Touching Base
TOM Biosciences: Developing Integrative Gene Therapies and Cell Therapies
In this chapter, TOM Biosciences discusses their plans to develop integrative gene therapies for liver diseases and cell therapies for autoimmune diseases, highlighting the importance of understanding clinical impact and patient perspective. They also mention their technology, PGI, which corrects gene defects and has potential applications in other disease areas.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
